AgingResearch.NewsJoin free

Abc pathway

Abc pathway has been studied in 1 paper since 2022: 1 observational study in people. The newest paper, Sep 2, 2022: “Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry”.

Exposure

1 paper studies it3 findingsUpdated

See all 1 papers on abc pathway

At a glance

The findings reach people, from one lab or study. 1 lab in 8 countries.

“Adherence to the ABC pathway in the clinically complex group reduced the risk of all-cause death (adjusted HR [aHR]: 0.72, 95%CI 0.58-0.91)”
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term RegistryBMC medicine2022doi:10.1186/s12916-022-02526-7

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

  • 1 lab in 8 countries
  • Funders: Aalborg Universitet and others
  • 3 of 3 findings with company ties
  • Humans1

What is abc pathway linked with?

3

Studies link abc pathway with 3 measures: Composite outcome, major adverse cardiovascular events and mortality.

Composite outcome

downin humans1

1 study

  1. Abc pathway is linked with a lower risk of composite outcome in clinically complex patients with atrial fibrillation (aHR 0.70, 95% CI 0.58-0.85).

    “composite outcome (aHR: 0.70, 95%CI: 0.58-0.85).”

    Humansin clinically complex patients with atrial fibrillationn = 8,289

    Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    BMC medicine

Major adverse cardiovascular events

downin humans1

1 study

  1. Abc pathway is linked with a lower risk of major adverse cardiovascular events in clinically complex patients with atrial fibrillation (aHR 0.68, 95% CI 0.52-0.87).

    “major adverse cardiovascular events (MACEs; aHR: 0.68, 95%CI 0.52-0.87)”

    Humansin clinically complex patients with atrial fibrillationn = 8,289

    Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    BMC medicine

More on Major adverse cardiovascular events

Mortality

downin humans1

1 study

  1. Abc pathway is linked with a lower risk of mortality in clinically complex patients with atrial fibrillation (aHR 0.72, 95% CI 0.58-0.91).

    “Adherence to the ABC pathway in the clinically complex group reduced the risk of all-cause death (adjusted HR [aHR]: 0.72, 95%CI 0.58-0.91)”

    Humansin clinically complex patients with atrial fibrillationn = 8,289

    Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    BMC medicine

Latest

Related